Loading…
Reported covered position: Assoc. Dir., Government Affairs
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Establishing the budget for the United States Government for fiscal year 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025.
Client: GENENTECH INC · Firm: GENENTECH, INC
Issues to theFY 2015 Department of Labor, Health and Human Services and Education , and Related Agencies Appropriations and issue related to S. Con. Res. 11 and H. Con Res 27; Issues related to FDA & HHS program funding, FY16 Labor Health and Human Services, and Education, and Related Agencies, and FY 16 Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Bills;
An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2016 and setting forth the appropriate budgetary levels for fiscal years 2017 through 2025.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
GENENTECH INC via GENENTECH, INC
2015 · second_quarter · Q2
Issues relating to corporate tax reform including the R&D tax credit and taxation of foreign-owned corporations; Issues related to tax reform and tax extenders.
Issues relating to U.S. trade policy
Source: Senate LDA
Client: GENENTECH INC · Firm: GENENTECH, INC
Issues to theFY 2015 Department of Labor, Health and Human Services and Education , and Related Agencies Appropriations and issue related to S. Con. Res. 11 and H. Con Res 27; Issues related to FDA & HHS program funding, FY16 Labor Health and Human Services, and Education, and Related Agencies, and FY 16 Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Bills;
Advocacy on maintaining the research and development tax credit; general tax issues and tax extenders (R&D tax credit) and tax treatment of foreign-owned US corporations.; S.2260, EXPIRE Act of 2014; H.R. 5771, Tax Increase Prevention Act of 2014;issues related to tax reform; Appropriations, R&D Tax credit; Tax: H.R. 5771 Tax Increase Prevention Act of 2014 (tax extenders) H.R. 2315 - 113th Congress (2013-2014) - Preserving Access to Orphan Drugs Act of 2013;
Advocacy on maintaining the research and development tax credit; general tax issues and tax extenders (R&D tax credit) and tax treatment of foreign-owned US corporations.; S.2260, EXPIRE Act of 2014; H.R. 5771, Tax Increase Prevention Act of 2014;issues related to tax reform; Appropriations, R&D Tax credit; Tax: H.R. 5771 Tax Increase Prevention Act of 2014 (tax extenders) H.R. 2315 - 113th Congress (2013-2014) - Preserving Access to Orphan Drugs Act of 2013;
Pandemic preparedness, Tamiflu, Medicare coverage of Cancer Drugs, Appropriations.; S.959, Pharmaceutical Compounding Quality and Accountability Act; H.R. 1416, Cancer Patient Protection Act of 2013; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; compounding issues; FY 13 Labor HHS Appropriations legislation; issues related to FDA user fee reauthorization; H.R. 942 S. 1577; S. 3187; Pedigree and biologics issues; H.R. 905: ASP issues; H.R. 5651; issues concerning drug compounding. Implementation of Patient Protection and Affordable Care Act; Legislation on public health preparedness and response related to pandemic influenza. Influenza Pandemic Preparedness federal, state and local levels. Legislation on screening, care and treatment for hepatitis; implementation of section 340B of the Public Health Service Act (42 U.S.C. 256b); Implementation of H.R. 1: Medicare Prescription Drug and Modernization Act of 2003; Issues relating to PDUFA stimulus. Avastin-use in breast cancer treatment: general patient reform isse: implementation of the Affordable Care Act of 2010; Issues relating to the treatment of biologics in international health programs.
Safeguarding America's Pharmaceuticals Act of 2013
Client: GENENTECH INC · Firm: GENENTECH, INC
Pandemic preparedness, Tamiflu, Medicare coverage of Cancer Drugs, Appropriations.; S.959, Pharmaceutical Compounding Quality and Accountability Act; H.R. 1416, Cancer Patient Protection Act of 2013; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; compounding issues; FY 13 Labor HHS Appropriations legislation; issues related to FDA user fee reauthorization; H.R. 942 S. 1577; S. 3187; Pedigree and biologics issues; H.R. 905: ASP issues; H.R. 5651; issues concerning drug compounding. Implementation of Patient Protection and Affordable Care Act; Legislation on public health preparedness and response related to pandemic influenza. Influenza Pandemic Preparedness federal, state and local levels. Legislation on screening, care and treatment for hepatitis; implementation of section 340B of the Public Health Service Act (42 U.S.C. 256b); Implementation of H.R. 1: Medicare Prescription Drug and Modernization Act of 2003; Issues relating to PDUFA stimulus. Avastin-use in breast cancer treatment: general patient reform isse: implementation of the Affordable Care Act of 2010; Issues relating to the treatment of biologics in international health programs.
Pandemic preparedness, Tamiflu, Medicare coverage of Cancer Drugs, Appropriations.; S.959, Pharmaceutical Compounding Quality and Accountability Act; H.R. 1416, Cancer Patient Protection Act of 2013; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; compounding issues; FY 13 Labor HHS Appropriations legislation; issues related to FDA user fee reauthorization; H.R. 942 S. 1577; S. 3187; Pedigree and biologics issues; H.R. 905: ASP issues; H.R. 5651; issues concerning drug compounding. Implementation of Patient Protection and Affordable Care Act; Legislation on public health preparedness and response related to pandemic influenza. Influenza Pandemic Preparedness federal, state and local levels. Legislation on screening, care and treatment for hepatitis; implementation of section 340B of the Public Health Service Act (42 U.S.C. 256b); Implementation of H.R. 1: Medicare Prescription Drug and Modernization Act of 2003; Issues relating to PDUFA stimulus. Avastin-use in breast cancer treatment: general patient reform isse: implementation of the Affordable Care Act of 2010; Issues relating to the treatment of biologics in international health programs.
Research and Development Tax Credit Extension Act of 2013
Client: GENENTECH INC · Firm: GENENTECH, INC
Pandemic preparedness, Tamiflu, Medicare coverage of Cancer Drugs, Appropriations.; S.959, Pharmaceutical Compounding Quality and Accountability Act; H.R. 1416, Cancer Patient Protection Act of 2013; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; compounding issues; FY 13 Labor HHS Appropriations legislation; issues related to FDA user fee reauthorization; H.R. 942 S. 1577; S. 3187; Pedigree and biologics issues; H.R. 905: ASP issues; H.R. 5651; issues concerning drug compounding. Implementation of Patient Protection and Affordable Care Act; Legislation on public health preparedness and response related to pandemic influenza. Influenza Pandemic Preparedness federal, state and local levels. Legislation on screening, care and treatment for hepatitis; implementation of section 340B of the Public Health Service Act (42 U.S.C. 256b); Implementation of H.R. 1: Medicare Prescription Drug and Modernization Act of 2003; Issues relating to PDUFA stimulus. Avastin-use in breast cancer treatment: general patient reform isse: implementation of the Affordable Care Act of 2010; Issues relating to the treatment of biologics in international health programs.
Ensuring Access to Quality Complex Rehabilitation Technology Act of 2013
Client: GENENTECH INC · Firm: GENENTECH, INC
Pandemic preparedness, Tamiflu, Medicare coverage of Cancer Drugs, Appropriations.; S.959, Pharmaceutical Compounding Quality and Accountability Act; H.R. 1416, Cancer Patient Protection Act of 2013; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; compounding issues; FY 13 Labor HHS Appropriations legislation; issues related to FDA user fee reauthorization; H.R. 942 S. 1577; S. 3187; Pedigree and biologics issues; H.R. 905: ASP issues; H.R. 5651; issues concerning drug compounding. Implementation of Patient Protection and Affordable Care Act; Legislation on public health preparedness and response related to pandemic influenza. Influenza Pandemic Preparedness federal, state and local levels. Legislation on screening, care and treatment for hepatitis; implementation of section 340B of the Public Health Service Act (42 U.S.C. 256b); Implementation of H.R. 1: Medicare Prescription Drug and Modernization Act of 2003; Issues relating to PDUFA stimulus. Avastin-use in breast cancer treatment: general patient reform isse: implementation of the Affordable Care Act of 2010; Issues relating to the treatment of biologics in international health programs.
Pandemic preparedness, Tamiflu, Medicare coverage of Cancer Drugs, Appropriations.; S.959, Pharmaceutical Compounding Quality and Accountability Act; H.R. 1416, Cancer Patient Protection Act of 2013; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; compounding issues; FY 13 Labor HHS Appropriations legislation; issues related to FDA user fee reauthorization; H.R. 942 S. 1577; S. 3187; Pedigree and biologics issues; H.R. 905: ASP issues; H.R. 5651; issues concerning drug compounding. Implementation of Patient Protection and Affordable Care Act; Legislation on public health preparedness and response related to pandemic influenza. Influenza Pandemic Preparedness federal, state and local levels. Legislation on screening, care and treatment for hepatitis; implementation of section 340B of the Public Health Service Act (42 U.S.C. 256b); Implementation of H.R. 1: Medicare Prescription Drug and Modernization Act of 2003; Issues relating to PDUFA stimulus. Avastin-use in breast cancer treatment: general patient reform isse: implementation of the Affordable Care Act of 2010; Issues relating to the treatment of biologics in international health programs.
Monitoring of the FY 14 appropriations bills and issues related to comprehensive tax reform; R&D Tax Credit issues; S. 3521, Family and Business Tax Cut Certainty Act of 2012; S. 1577 Greater Research Opportunities with Tax Help Act; H.R. 942, American Research and Competitiveness Act of 2011; H.R. 8; Research and Development Tax credit, general tax issues and tax extenders (R&D tax credit) and tax treatment of foreign-owned US corporations.
Tax reform; general tax issues and tax extenders (R&D tax credit) and tax; Research and Development Tax credit; Specific issues lobbied (bill numbers): R&D Tax Credit issues; S. 3521, Family and Business Tax Cut Certainty Act of 2012; S. 1577 Greater Research Opportunities with Tax Help Act; H.R. 942, American Research and Competitiveness Act of 2011; H.R. 8
Pandemic preparedness, Tamiflu, Medicare coverage of Cancer Drugs, Appropriations.; S.959, Pharmaceutical Compounding Quality and Accountability Act; H.R. 1416, Cancer Patient Protection Act of 2013; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; compounding issues; FY 13 Labor HHS Appropriations legislation; issues related to FDA user fee reauthorization; H.R. 942 S. 1577; S. 3187; Pedigree and biologics issues; H.R. 905: ASP issues; H.R. 5651; issues concerning drug compounding. Implementation of Patient Protection and Affordable Care Act; Legislation on public health preparedness and response related to pandemic influenza. Influenza Pandemic Preparedness federal, state and local levels. Legislation on screening, care and treatment for hepatitis; implementation of section 340B of the Public Health Service Act (42 U.S.C. 256b); Implementation of H.R. 1: Medicare Prescription Drug and Modernization Act of 2003; Issues relating to PDUFA stimulus. Avastin-use in breast cancer treatment: general patient reform isse: implementation of the Affordable Care Act of 2010; Issues relating to the treatment of biologics in international health programs.
Pharmaceutical Quality, Security, and Accountability Act
Client: GENENTECH INC · Firm: GENENTECH, INC
Pandemic preparedness, Tamiflu, Medicare coverage of Cancer Drugs, Appropriations.; S.959, Pharmaceutical Compounding Quality and Accountability Act; H.R. 1416, Cancer Patient Protection Act of 2013; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; compounding issues; FY 13 Labor HHS Appropriations legislation; issues related to FDA user fee reauthorization; H.R. 942 S. 1577; S. 3187; Pedigree and biologics issues; H.R. 905: ASP issues; H.R. 5651; issues concerning drug compounding. Implementation of Patient Protection and Affordable Care Act; Legislation on public health preparedness and response related to pandemic influenza. Influenza Pandemic Preparedness federal, state and local levels. Legislation on screening, care and treatment for hepatitis; implementation of section 340B of the Public Health Service Act (42 U.S.C. 256b); Implementation of H.R. 1: Medicare Prescription Drug and Modernization Act of 2003; Issues relating to PDUFA stimulus. Avastin-use in breast cancer treatment: general patient reform isse: implementation of the Affordable Care Act of 2010; Issues relating to the treatment of biologics in international health programs.
Monitoring of the FY 14 appropriations bills and issues related to comprehensive tax reform; R&D Tax Credit issues; S. 3521, Family and Business Tax Cut Certainty Act of 2012; S. 1577 Greater Research Opportunities with Tax Help Act; H.R. 942, American Research and Competitiveness Act of 2011; H.R. 8; Research and Development Tax credit, general tax issues and tax extenders (R&D tax credit) and tax treatment of foreign-owned US corporations.
Tax reform; general tax issues and tax extenders (R&D tax credit) and tax; Research and Development Tax credit; Specific issues lobbied (bill numbers): R&D Tax Credit issues; S. 3521, Family and Business Tax Cut Certainty Act of 2012; S. 1577 Greater Research Opportunities with Tax Help Act; H.R. 942, American Research and Competitiveness Act of 2011; H.R. 8
American Research and Competitiveness Act of 2011
Client: GENENTECH INC · Firm: GENENTECH, INC
Tax reform; general tax issues and tax extenders (R&D tax credit) and tax; Research and Development Tax credit; Specific issues lobbied (bill numbers): R&D Tax Credit issues; S. 3521, Family and Business Tax Cut Certainty Act of 2012; S. 1577 Greater Research Opportunities with Tax Help Act; H.R. 942, American Research and Competitiveness Act of 2011; H.R. 8
American Research and Competitiveness Act of 2011
Client: GENENTECH INC · Firm: GENENTECH, INC
Monitoring of the FY 14 appropriations bills and issues related to comprehensive tax reform; R&D Tax Credit issues; S. 3521, Family and Business Tax Cut Certainty Act of 2012; S. 1577 Greater Research Opportunities with Tax Help Act; H.R. 942, American Research and Competitiveness Act of 2011; H.R. 8; Research and Development Tax credit, general tax issues and tax extenders (R&D tax credit) and tax treatment of foreign-owned US corporations.
Federal Aviation Administration Extension Act of 2010
Client: GENENTECH INC · Firm: GENENTECH, INC
Pandemic preparedness, Tamiflu, Medicare coverage of Cancer Drugs, Appropriations.; S.959, Pharmaceutical Compounding Quality and Accountability Act; H.R. 1416, Cancer Patient Protection Act of 2013; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; compounding issues; FY 13 Labor HHS Appropriations legislation; issues related to FDA user fee reauthorization; H.R. 942 S. 1577; S. 3187; Pedigree and biologics issues; H.R. 905: ASP issues; H.R. 5651; issues concerning drug compounding. Implementation of Patient Protection and Affordable Care Act; Legislation on public health preparedness and response related to pandemic influenza. Influenza Pandemic Preparedness federal, state and local levels. Legislation on screening, care and treatment for hepatitis; implementation of section 340B of the Public Health Service Act (42 U.S.C. 256b); Implementation of H.R. 1: Medicare Prescription Drug and Modernization Act of 2003; Issues relating to PDUFA stimulus. Avastin-use in breast cancer treatment: general patient reform isse: implementation of the Affordable Care Act of 2010; Issues relating to the treatment of biologics in international health programs.
Generating Antibiotic Incentives Now Act of 2011
Client: GENENTECH INC · Firm: GENENTECH, INC
Implementation of H.R. 1: Medicare Prescription Drug and Modernization Act of 2003; Issues relating to PDUFA,stimulus. Issues relating to comparative effectiveness and CMS coverage of FDA approved therapties. Issues related to the PPS ruel involving stroke guidelines. Implementation of the follow-on biologice provisions in P.L. 111-148- "Patient Protection and Affordable Care Act"; legislation on public health preparedness and response related to pandemic influenza. Influenz Pandemic Preparedness federal, state and local levels. Legislation on screening, care and treatment for hepatitis; FDA Approval and enforcement issues. Issues relating to S.3187, FDA Safety and Innovation Act. Issues relating to antibiotic development incentives in HR 2182 and S 1734, "Generating Antibiotic Incentives Now Act of 2011"; Prescription Drug User Fee Act (PDUFA) Reauthorization;Issues related to the implementationof the Affordable Care Act of 2010;
FY14 appropriations bills, including issues related to FDA funding and drug approval/review oversight process; issues related to comprehensive tax U.S. corporations, and tax extenders, including R&D tax credit. S.3521, Family and Business Tax Cut Certanity Act of 2012 (tax "extenders"). Corporate tax reform issues. Fiscal cliff legislation. American Taxpayer relief act (HR 8); R&D Tax Credit issues; S. 3521, S.1577, Greater Research Opportunities with Tax Help Act: H.R. 942, American Research and Competitiveness Act of 2011; HR. 8; Research and Development Tax credit, year-end tax issues: Monitoring proposals on US tax treatment of foreign-owned US corporations;
American Research and Competitiveness Act of 2011
Client: GENENTECH INC · Firm: GENENTECH, INC
R&D Tax Credit (H.R. 942), FDA Appropriations, PDUFA Reauthorization; general tax issues and tax extenders (R&D tax credit) and tax treatment of foreign-owned U.S. corporations; Worked to garner support for H.R. 942, the AmericanResearch and Competitiveness Act of 2011; Monitoring proposals on US tax treatment of foreign-owned U.S. corporations;
American Research and Competitiveness Act of 2011
Client: GENENTECH INC · Firm: GENENTECH, INC
FY14 appropriations bills, including issues related to FDA funding and drug approval/review oversight process; issues related to comprehensive tax U.S. corporations, and tax extenders, including R&D tax credit. S.3521, Family and Business Tax Cut Certanity Act of 2012 (tax "extenders"). Corporate tax reform issues. Fiscal cliff legislation. American Taxpayer relief act (HR 8); R&D Tax Credit issues; S. 3521, S.1577, Greater Research Opportunities with Tax Help Act: H.R. 942, American Research and Competitiveness Act of 2011; HR. 8; Research and Development Tax credit, year-end tax issues: Monitoring proposals on US tax treatment of foreign-owned US corporations;
To specify the priority of the obligations of the United States Government if the debt ceiling is reached, to provide for an emergency appropriation of funds to pay for certain defense and national security obligations during a gap in funding, and for other purposes.
Client: GENENTECH INC · Firm: GENENTECH, INC
Intellectual Property and Process Patent Issues; HR 1908, Patent Reform Act (all provisions); S.23 - Patent Reform Act; General Patent Reform Issues; Specfic issues lobbied (bill numbers): Patent reform legislation
Patent Reform Act; general Patent reform issues; H.R.243 Patent Lawsuit Reform Act of 2011; H.R. 1249 Leahy-Smith America Invents Act S.23 - America Invents Act;
Advocacy related ensuring access to necessary medicines; implementation of H.R. and Modernization Act of 2003; Issues relating to PDUFA, stimulus, issues relating comparative effectiveness and CMS coverage of FDA approved therapies; Medicare coverage and payment of Part B drugs and biologics; Support for H.R. 452 Medicare Decision Accountability Act of 2011 and S.668: "Health Care Bureaucrats Elimination Act"; FDA approval and enforcement issues,340B payment and implementation issues; Medicare issues; Monitor implementation of Medicare Pharmaceutical coverage and reimbursement 340B provisions of the Affordable Care Act
Promoting Innovation and Access to Life-Saving Medicine Act
Client: GENENTECH INC · Firm: GENENTECH, INC
Avastin, Lucentis, FDA, Appropriations; Issues concerning clinical trias. General health care reform (Patient Protection and Affordable Care Act). Congressional oversight issues; Legislation on public health preparedness and response to pandemic influenza. Influenza Pandemic Preparedness federal, state and local levels; FDA approval and enforcement issues; Prescription Drug User Fee Act (PDUFA), Avastin - use in breast cancer treatment, macular degeneration, S.726/HR 1427 - Promoting Innovation and Access to Life-Saving Medicine Act; HR 1548 - Pathway for Biosimilars Act, General support for Genentech products; HR1/1473 health care funding : FY 12 Labor HHS Appropriations legislation.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: GENENTECH INC · Firm: GENENTECH, INC
Avastin, Lucentis,FDA Appropriations; Issues concerning clincial trials. General health care reform (Patient Protection and Affordable Care Act). Congressional oversight issues; Legislation on public health preparedness and response to pandemic influenza. Influenza Pandemic Preparedness federal, state and local levels; FDA approval and enforcement issues; Presciption Drug User Fee Act (PDUFA), Avastin -use in breast cancer treatment, dry macular degeneration; S.726/HR 1427 - Promoting Innovation and Access to Life-Saving Medicine Act; HR 1548 - Pathway for Biosimilars Act, General support for Genentech products; HR1/1473 health care funding: FY 12 Labor HHS Appropriations legislation
Avastin, Lucentis,FDA Appropriations; Issues concerning clincial trials. General health care reform (Patient Protection and Affordable Care Act). Congressional oversight issues; Legislation on public health preparedness and response to pandemic influenza. Influenza Pandemic Preparedness federal, state and local levels; FDA approval and enforcement issues; Presciption Drug User Fee Act (PDUFA), Avastin -use in breast cancer treatment, dry macular degeneration; S.726/HR 1427 - Promoting Innovation and Access to Life-Saving Medicine Act; HR 1548 - Pathway for Biosimilars Act, General support for Genentech products; HR1/1473 health care funding: FY 12 Labor HHS Appropriations legislation
Avastin, Lucentis, FDA, Appropriations; Issues concerning clinical trias. General health care reform (Patient Protection and Affordable Care Act). Congressional oversight issues; Legislation on public health preparedness and response to pandemic influenza. Influenza Pandemic Preparedness federal, state and local levels; FDA approval and enforcement issues; Prescription Drug User Fee Act (PDUFA), Avastin - use in breast cancer treatment, macular degeneration, S.726/HR 1427 - Promoting Innovation and Access to Life-Saving Medicine Act; HR 1548 - Pathway for Biosimilars Act, General support for Genentech products; HR1/1473 health care funding : FY 12 Labor HHS Appropriations legislation.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: GENENTECH INC · Firm: GENENTECH, INC
Avastin, Lucentis,FDA Appropriations; Issues concerning clincial trials. General health care reform (Patient Protection and Affordable Care Act). Congressional oversight issues; Legislation on public health preparedness and response to pandemic influenza. Influenza Pandemic Preparedness federal, state and local levels; FDA approval and enforcement issues; Presciption Drug User Fee Act (PDUFA), Avastin -use in breast cancer treatment, dry macular degeneration; S.726/HR 1427 - Promoting Innovation and Access to Life-Saving Medicine Act; HR 1548 - Pathway for Biosimilars Act, General support for Genentech products; HR1/1473 health care funding: FY 12 Labor HHS Appropriations legislation
Promoting Innovation and Access to Life-Saving Medicine Act
Client: GENENTECH INC · Firm: GENENTECH, INC
Avastin, Lucentis, FDA, Appropriations; Issues concerning clinical trias. General health care reform (Patient Protection and Affordable Care Act). Congressional oversight issues; Legislation on public health preparedness and response to pandemic influenza. Influenza Pandemic Preparedness federal, state and local levels; FDA approval and enforcement issues; Prescription Drug User Fee Act (PDUFA), Avastin - use in breast cancer treatment, macular degeneration, S.726/HR 1427 - Promoting Innovation and Access to Life-Saving Medicine Act; HR 1548 - Pathway for Biosimilars Act, General support for Genentech products; HR1/1473 health care funding : FY 12 Labor HHS Appropriations legislation.
S.515 & H.R. 1260 - Patent Reform Act of 2009
Promoting Innovation and Access to Life-Saving Medicine Act
Client: GENENTECH INC · Firm: GENENTECH, INC
Medicare issues; payment policies for prescription drugs; implementation of H.R.1; Medicare Prescription Drug and Modernization Act of 2003; Issues relating to PDUFA, stimulus; physician payment disclosure including S.301; Physician Payments Sunshine Act of 2009; HR 3962, Affordable Health Care for Americans Act; HR 3590, Patient Protection and Affordable Care Act; H.R.4872, the Reconciliation Act of 2010; Follow-on biologics including H.R. 154, the Pathway to Biosimilars Act; S726/H.R. 1427 Promoting innovation and access to Life Savings Medicines Act; HR 3962, Affordable Health Care for America Act; Compartiveffectiveness legislation S. 1213; Patient-Centered Outcomes Research Act of 2009; HR 3200, America's Health Future Act; H.R. 1548-Pathway for Dissimilar Act; Legislative changes in health care reform bill regarding dissimilar; Follow-on biolotics provisions in P.L. 111-148 "Patient protection and Affordable Care Act", Affordable Health Choice Act; American Health Future Act of 2009; Pharmaceutical Import Safety legislation.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: GENENTECH INC · Firm: GENENTECH, INC
Labor HHS appropriations stock piling anti-virals for pandemic influenza; Cancer Research Issues - S.3686/HR_, Labor, HHS Appropriations Bill for FY2011; Monitoring the implementation for the Patient Protection and Affordable Care Act, including provisions related to comparative effectiveness research and a regulatory pathway for biosimilars; H.R.1 - Pandemic influenza funding: H.R.1105 Omnibus Appropriations Act of 2010, Food Safety Bill, H.R. 4872 Health Care& Education Reconciliation Act of 2011; issues concerning clincial trials; general health care reform (Patient Protection and Affordable Care Act); Congressional oversight issues; FDA approval and enforcement issues; Pandemic preparedness; Tamiflu; Avastin-breast cancer; following all issues related to health care reform; S.726/HR 1427 - promotiong innovation and access to life-saving Medicine Act; HR 1548 - Pathway for Biosimilars Act; General support for Genentech products; monitor and report on issues relate to implementation to health care reform; H.R. 1548 - Pathway for Biosimilars Act
Medicare issues; payment policies for prescription drugs; implementation of H.R.1; Medicare Prescription Drug and Modernization Act of 2003; Issues relating to PDUFA, stimulus; physician payment disclosure including S.301; Physician Payments Sunshine Act of 2009; HR 3962, Affordable Health Care for Americans Act; HR 3590, Patient Protection and Affordable Care Act; H.R.4872, the Reconciliation Act of 2010; Follow-on biologics including H.R. 154, the Pathway to Biosimilars Act; S726/H.R. 1427 Promoting innovation and access to Life Savings Medicines Act; HR 3962, Affordable Health Care for America Act; Compartiveffectiveness legislation S. 1213; Patient-Centered Outcomes Research Act of 2009; HR 3200, America's Health Future Act; H.R. 1548-Pathway for Dissimilar Act; Legislative changes in health care reform bill regarding dissimilar; Follow-on biolotics provisions in P.L. 111-148 "Patient protection and Affordable Care Act", Affordable Health Choice Act; American Health Future Act of 2009; Pharmaceutical Import Safety legislation.
Labor HHS appropriations stock piling anti-virals for pandemic influenza; Cancer Research Issues - S.3686/HR_, Labor, HHS Appropriations Bill for FY2011; Monitoring the implementation for the Patient Protection and Affordable Care Act, including provisions related to comparative effectiveness research and a regulatory pathway for biosimilars; H.R.1 - Pandemic influenza funding: H.R.1105 Omnibus Appropriations Act of 2010, Food Safety Bill, H.R. 4872 Health Care& Education Reconciliation Act of 2011; issues concerning clincial trials; general health care reform (Patient Protection and Affordable Care Act); Congressional oversight issues; FDA approval and enforcement issues; Pandemic preparedness; Tamiflu; Avastin-breast cancer; following all issues related to health care reform; S.726/HR 1427 - promotiong innovation and access to life-saving Medicine Act; HR 1548 - Pathway for Biosimilars Act; General support for Genentech products; monitor and report on issues relate to implementation to health care reform; H.R. 1548 - Pathway for Biosimilars Act
Medicare issues; payment policies for prescription drugs; implementation of H.R.1; Medicare Prescription Drug and Modernization Act of 2003; Issues relating to PDUFA, stimulus; physician payment disclosure including S.301; Physician Payments Sunshine Act of 2009; HR 3962, Affordable Health Care for Americans Act; HR 3590, Patient Protection and Affordable Care Act; H.R.4872, the Reconciliation Act of 2010; Follow-on biologics including H.R. 154, the Pathway to Biosimilars Act; S726/H.R. 1427 Promoting innovation and access to Life Savings Medicines Act; HR 3962, Affordable Health Care for America Act; Compartiveffectiveness legislation S. 1213; Patient-Centered Outcomes Research Act of 2009; HR 3200, America's Health Future Act; H.R. 1548-Pathway for Dissimilar Act; Legislative changes in health care reform bill regarding dissimilar; Follow-on biolotics provisions in P.L. 111-148 "Patient protection and Affordable Care Act", Affordable Health Choice Act; American Health Future Act of 2009; Pharmaceutical Import Safety legislation.
Labor HHS Appropriations - S.3230 & H.R. 3042, Homeland Security Appropriations S.3181 and HR 6947; Congress and Federal agencies: US House of Representatives: US Senate: HHS; Dept. of Homeland Security; Executive Office of the President; Office of Personnel Manangement; Dept., of Veteran Affairs
America's Affordable Health Choices Act of 2009
Client: GENENTECH INC · Firm: GENENTECH, INC
Medicare issues; payment policies for prescription drugs; implementation of H.R.1; Medicare Prescription Drug and Modernization Act of 2003; Issues relating to PDUFA, stimulus; physician payment disclosure including S.301; Physician Payments Sunshine Act of 2009; HR 3962, Affordable Health Care for Americans Act; HR 3590, Patient Protection and Affordable Care Act; H.R.4872, the Reconciliation Act of 2010; Follow-on biologics including H.R. 154, the Pathway to Biosimilars Act; S726/H.R. 1427 Promoting innovation and access to Life Savings Medicines Act; HR 3962, Affordable Health Care for America Act; Compartiveffectiveness legislation S. 1213; Patient-Centered Outcomes Research Act of 2009; HR 3200, America's Health Future Act; H.R. 1548-Pathway for Dissimilar Act; Legislative changes in health care reform bill regarding dissimilar; Follow-on biolotics provisions in P.L. 111-148 "Patient protection and Affordable Care Act", Affordable Health Choice Act; American Health Future Act of 2009; Pharmaceutical Import Safety legislation.
Medicare issues; payment policies for prescription drugs; implementation of H.R.1; Medicare Prescription Drug and Modernization Act of 2003; Issues relating to PDUFA, stimulus; physician payment disclosure including S.301; Physician Payments Sunshine Act of 2009; HR 3962, Affordable Health Care for Americans Act; HR 3590, Patient Protection and Affordable Care Act; H.R.4872, the Reconciliation Act of 2010; Follow-on biologics including H.R. 154, the Pathway to Biosimilars Act; S726/H.R. 1427 Promoting innovation and access to Life Savings Medicines Act; HR 3962, Affordable Health Care for America Act; Compartiveffectiveness legislation S. 1213; Patient-Centered Outcomes Research Act of 2009; HR 3200, America's Health Future Act; H.R. 1548-Pathway for Dissimilar Act; Legislative changes in health care reform bill regarding dissimilar; Follow-on biolotics provisions in P.L. 111-148 "Patient protection and Affordable Care Act", Affordable Health Choice Act; American Health Future Act of 2009; Pharmaceutical Import Safety legislation.
Medicare issues; payment policies for prescription drugs; implementation of H.R.1; Medicare Prescription Drug and Modernization Act of 2003; Issues relating to PDUFA, stimulus; physician payment disclosure including S.301; Physician Payments Sunshine Act of 2009; HR 3962, Affordable Health Care for Americans Act; HR 3590, Patient Protection and Affordable Care Act; H.R.4872, the Reconciliation Act of 2010; Follow-on biologics including H.R. 154, the Pathway to Biosimilars Act; S726/H.R. 1427 Promoting innovation and access to Life Savings Medicines Act; HR 3962, Affordable Health Care for America Act; Compartiveffectiveness legislation S. 1213; Patient-Centered Outcomes Research Act of 2009; HR 3200, America's Health Future Act; H.R. 1548-Pathway for Dissimilar Act; Legislative changes in health care reform bill regarding dissimilar; Follow-on biolotics provisions in P.L. 111-148 "Patient protection and Affordable Care Act", Affordable Health Choice Act; American Health Future Act of 2009; Pharmaceutical Import Safety legislation.
Labor HHS Appropriations - S.3230 & H.R. 3042, Homeland Security Appropriations S.3181 and HR 6947; Congress and Federal agencies: US House of Representatives: US Senate: HHS; Dept. of Homeland Security; Executive Office of the President; Office of Personnel Manangement; Dept., of Veteran Affairs
Labor HHS Appropriations - S.3230 & H.R. 3042, Homeland Security Appropriations S.3181 and HR 6947; Congress and Federal agencies: US House of Representatives: US Senate: HHS; Dept. of Homeland Security; Executive Office of the President; Office of Personnel Manangement; Dept., of Veteran Affairs
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2011
Client: GENENTECH INC · Firm: GENENTECH, INC
Labor HHS appropriations stock piling anti-virals for pandemic influenza; Cancer Research Issues - S.3686/HR_, Labor, HHS Appropriations Bill for FY2011; Monitoring the implementation for the Patient Protection and Affordable Care Act, including provisions related to comparative effectiveness research and a regulatory pathway for biosimilars; H.R.1 - Pandemic influenza funding: H.R.1105 Omnibus Appropriations Act of 2010, Food Safety Bill, H.R. 4872 Health Care& Education Reconciliation Act of 2011; issues concerning clincial trials; general health care reform (Patient Protection and Affordable Care Act); Congressional oversight issues; FDA approval and enforcement issues; Pandemic preparedness; Tamiflu; Avastin-breast cancer; following all issues related to health care reform; S.726/HR 1427 - promotiong innovation and access to life-saving Medicine Act; HR 1548 - Pathway for Biosimilars Act; General support for Genentech products; monitor and report on issues relate to implementation to health care reform; H.R. 1548 - Pathway for Biosimilars Act
S.515 & H.R. 1260 - Patent Reform Act of 2009
Promoting Innovation and Access to Life-Saving Medicine Act
Client: GENENTECH INC · Firm: GENENTECH, INC
Medicare issues; payment policies for prescription drugs; implementation of H.R.1; Medicare Prescription Drug and Modernization Act of 2003; Issues relating to PDUFA, stimulus; physician payment disclosure including S.301; Physician Payments Sunshine Act of 2009; HR 3962, Affordable Health Care for Americans Act; HR 3590, Patient Protection and Affordable Care Act; H.R.4872, the Reconciliation Act of 2010; Follow-on biologics including H.R. 154, the Pathway to Biosimilars Act; S726/H.R. 1427 Promoting innovation and access to Life Savings Medicines Act; HR 3962, Affordable Health Care for America Act; Compartiveffectiveness legislation S. 1213; Patient-Centered Outcomes Research Act of 2009; HR 3200, America's Health Future Act; H.R. 1548-Pathway for Dissimilar Act; Legislative changes in health care reform bill regarding dissimilar; Follow-on biolotics provisions in P.L. 111-148 "Patient protection and Affordable Care Act", Affordable Health Choice Act; American Health Future Act of 2009; Pharmaceutical Import Safety legislation.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: GENENTECH INC · Firm: GENENTECH, INC
Labor HHS appropriations stock piling anti-virals for pandemic influenza; Cancer Research Issues - S.3686/HR_, Labor, HHS Appropriations Bill for FY2011; Monitoring the implementation for the Patient Protection and Affordable Care Act, including provisions related to comparative effectiveness research and a regulatory pathway for biosimilars; H.R.1 - Pandemic influenza funding: H.R.1105 Omnibus Appropriations Act of 2010, Food Safety Bill, H.R. 4872 Health Care& Education Reconciliation Act of 2011; issues concerning clincial trials; general health care reform (Patient Protection and Affordable Care Act); Congressional oversight issues; FDA approval and enforcement issues; Pandemic preparedness; Tamiflu; Avastin-breast cancer; following all issues related to health care reform; S.726/HR 1427 - promotiong innovation and access to life-saving Medicine Act; HR 1548 - Pathway for Biosimilars Act; General support for Genentech products; monitor and report on issues relate to implementation to health care reform; H.R. 1548 - Pathway for Biosimilars Act
Physician Pathology Services Continuity Act of 2007
Client: GENENTECH INC · Firm: GENENTECH, INC
Labor HHS appropriations stock piling anti-virals for pandemic influenza; Cancer Research Issues - S.3686/HR_, Labor, HHS Appropriations Bill for FY2011; Monitoring the implementation for the Patient Protection and Affordable Care Act, including provisions related to comparative effectiveness research and a regulatory pathway for biosimilars; H.R.1 - Pandemic influenza funding: H.R.1105 Omnibus Appropriations Act of 2010, Food Safety Bill, H.R. 4872 Health Care& Education Reconciliation Act of 2011; issues concerning clincial trials; general health care reform (Patient Protection and Affordable Care Act); Congressional oversight issues; FDA approval and enforcement issues; Pandemic preparedness; Tamiflu; Avastin-breast cancer; following all issues related to health care reform; S.726/HR 1427 - promotiong innovation and access to life-saving Medicine Act; HR 1548 - Pathway for Biosimilars Act; General support for Genentech products; monitor and report on issues relate to implementation to health care reform; H.R. 1548 - Pathway for Biosimilars Act
American Middle Class Tax (AMT) Relief Act of 2007
Client: GENENTECH INC · Firm: GENENTECH, INC
Medicare issues; payment policies for prescription drugs; implementation of H.R.1; Medicare Prescription Drug and Modernization Act of 2003; Issues relating to PDUFA, stimulus; physician payment disclosure including S.301; Physician Payments Sunshine Act of 2009; HR 3962, Affordable Health Care for Americans Act; HR 3590, Patient Protection and Affordable Care Act; H.R.4872, the Reconciliation Act of 2010; Follow-on biologics including H.R. 154, the Pathway to Biosimilars Act; S726/H.R. 1427 Promoting innovation and access to Life Savings Medicines Act; HR 3962, Affordable Health Care for America Act; Compartiveffectiveness legislation S. 1213; Patient-Centered Outcomes Research Act of 2009; HR 3200, America's Health Future Act; H.R. 1548-Pathway for Dissimilar Act; Legislative changes in health care reform bill regarding dissimilar; Follow-on biolotics provisions in P.L. 111-148 "Patient protection and Affordable Care Act", Affordable Health Choice Act; American Health Future Act of 2009; Pharmaceutical Import Safety legislation.
Medicare issues; payment policies for prescription drugs; implementation of H.R.1; Medicare Prescription Drug and Modernization Act of 2003; Issues relating to PDUFA, stimulus; physician payment disclosure including S.301; Physician Payments Sunshine Act of 2009; HR 3962, Affordable Health Care for Americans Act; HR 3590, Patient Protection and Affordable Care Act; H.R.4872, the Reconciliation Act of 2010; Follow-on biologics including H.R. 154, the Pathway to Biosimilars Act; S726/H.R. 1427 Promoting innovation and access to Life Savings Medicines Act; HR 3962, Affordable Health Care for America Act; Compartiveffectiveness legislation S. 1213; Patient-Centered Outcomes Research Act of 2009; HR 3200, America's Health Future Act; H.R. 1548-Pathway for Dissimilar Act; Legislative changes in health care reform bill regarding dissimilar; Follow-on biolotics provisions in P.L. 111-148 "Patient protection and Affordable Care Act", Affordable Health Choice Act; American Health Future Act of 2009; Pharmaceutical Import Safety legislation.
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: GENENTECH INC · Firm: GENENTECH, INC
Labor HHS appropriations stock piling anti-virals for pandemic influenza; Cancer Research Issues - S.3686/HR_, Labor, HHS Appropriations Bill for FY2011; Monitoring the implementation for the Patient Protection and Affordable Care Act, including provisions related to comparative effectiveness research and a regulatory pathway for biosimilars; H.R.1 - Pandemic influenza funding: H.R.1105 Omnibus Appropriations Act of 2010, Food Safety Bill, H.R. 4872 Health Care& Education Reconciliation Act of 2011; issues concerning clincial trials; general health care reform (Patient Protection and Affordable Care Act); Congressional oversight issues; FDA approval and enforcement issues; Pandemic preparedness; Tamiflu; Avastin-breast cancer; following all issues related to health care reform; S.726/HR 1427 - promotiong innovation and access to life-saving Medicine Act; HR 1548 - Pathway for Biosimilars Act; General support for Genentech products; monitor and report on issues relate to implementation to health care reform; H.R. 1548 - Pathway for Biosimilars Act
Department of Homeland Security Appropriations Act, 2009
Client: GENENTECH INC · Firm: GENENTECH, INC
Labor HHS Appropriations - S.3230 & H.R. 3042, Homeland Security Appropriations S.3181 and HR 6947; Congress and Federal agencies: US House of Representatives: US Senate: HHS; Dept. of Homeland Security; Executive Office of the President; Office of Personnel Manangement; Dept., of Veteran Affairs
Issues to theFY 2015 Department of Labor, Health and Human Services and Education , and Related Agencies Appropriations and issue related to S. Con. Res. 11 and H. Con Res 27; Issues related to FDA & HHS program funding, FY16 Labor Health and Human Services, and Education, and Related Agencies, and FY 16 Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Bills;
general lobbying; MMM: Implementation of P.L. 108-173, matters related to Medicare and Medicaid Coverage and Reimbursement; issues relating to Prescription Drug User Fee Act and ASP +6; issues related to comparative effectiveness and follow-on biologics, issues related to FDA repeal of Avastin; issues related to coverage of Lucentis and Avastin; Issues related to 340B;
Public Law 111-148, the Patient Protection and Affordable Care Act 0 Implementation issues related to FDA approval of follow on biologics and length of data exclusivity period, 340B drug pricing program, structure of the Medicare prescription drug benefit.; Public Law 111-152, the Health Care and Education Reconciliation Act of 2010 - Implementation issues related to Medicare and Medicaid reimbursement, fees assessed on the pharmaceutical industry, design and structure of the Medicare prescription; General issues and congressional oversight related to FDA approval and CMS coverage decisions regarding Avastin and Lucentis.; Held discussions with Administration staff about 340B program requirements on participating pharmaceutical manufacturers., Held preliminary discussion with Administration staff on anti-viral drugs in the strategic national stockpile.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH INC via GENENTECH, INC
2015 · first_quarter · Q1
Issues relating to U.S. trade policy
Issues related to FDA & HHS program funding, FY16 Labor Health and Human Services, and Education, and Related Agencies, and FY 16 Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Bills; Following issues related to the budget and appropriations process. Issues related to FY 2015 Departments of Labor, Health and Human Services, and Education, and related agencies.
Transpacific Partnership Agreement.
Monitor Drug Safety and pedigree legislation. Monitor legislation and oversight on compounding pharmacies; 340(b) Drug Discount Program.
general tax issues and tax extenders (R&D tax credit) and tax treatment of foreign-owned US corporations. Follow issues related tax reform; Corporate tax reform; Issues relating to corporate tax reform including the R&D tax credit andtaxation of foreign-owned corporations with US subsidiaries
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH INC via GENENTECH, INC
2014 · fourth_quarter · Q4
Advocacy on maintaining the research and development tax credit; general tax issues and tax extenders (R&D tax credit) and tax treatment of foreign-owned US corporations.; S.2260, EXPIRE Act of 2014; H.R. 5771, Tax Increase Prevention Act of 2014;issues related to tax reform; Appropriations, R&D Tax credit; Tax: H.R. 5771 Tax Increase Prevention Act of 2014 (tax extenders) H.R. 2315 - 113th Congress (2013-2014) - Preserving Access to Orphan Drugs Act of 2013;
Trade related issues;
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH INC via GENENTECH, INC
2014 · third_quarter · Q3
BUD: Following issues related to the budget and appropriations process FY 14 appropriations for FDA as well as the potential outcomes for negotiations on altering sequestration targets via legislation.; TAX - general tax issues and tax extenders (R&D tax credit) and tax treatment of foreign-owned US corporations. Issues related to FDA & HHS program funding, FY15 Labor Health and Human Services, and Education, and Related Agencies, H.R. 4800, and FY 15 Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Bills.
TAX - general tax issues and tax extenders (R&D tax credit) and tax treatment of foreign-owned US corporations.; Tax reform, general corporate and international taxation.
Cyber Security, transpacific partnership; Intellectual Property and Process Patent Issues - (all provisions)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH INC via GENENTECH, INC
2014 · second_quarter · 2A
Intellectual Property and Process Patent Issues - (all provisions), Cyber security, Transpacific partnership
general tax issues and tax extenders (R&D tax credit) and tax treatment of foreign-owned US corporations, Tax reform, 340 B pricing, research and development tax credit, pandemic preparedness, federal appropriations., Issues related to comprehensive tax reformed the tax treatment of foreign-owned U.S. corporations. S__, Expiring Provisions Improvement Reform and Efficiency (EXPIRE) Act (tax extenders), including the R&D tax credit.
BUD: FY15 Labor, HHS and Education Appropriations related to preparedness for pandemic influenza, HIV/AIDS, hepatitis screening, care and treatment, and access to breast cancer treatment, Issues related to FDA & HHS program funding, FY15 Labor Health and Human Services, and Education, and Related Agencies, H.R. 4800, and FY 15 Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Bills, Following issues related to the budget and appropriations process FY 13 appropriations for FDA as well as the potential outcomes for negotiations on altering sequestration targets via legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH INC via GENENTECH, INC
2014 · second_quarter · Q2
BUD: FY15 Labor, HHS and Education Appropriations related to preparedness for pandemic influenza, HIV/AIDS, hepatitis screening, care and treatment, and access to breast cancer treatment, Issues related to FDA & HHS program funding, FY15 Labor Health and Human Services, and Education, and Related Agencies, H.R. 4800, and FY 15 Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Bills, Following issues related to the budget and appropriations process FY 13 appropriations for FDA as well as the potential outcomes for negotiations on altering sequestration targets via legislation.
general tax issues and tax extenders (R&D tax credit) and tax treatment of foreign-owned US corporations, Tax reform, 340 B pricing, research and development tax credit, pandemic preparedness, federal appropriations., Issues related to comprehensive tax reformed the tax treatment of foreign-owned U.S. corporations. S__, Expiring Provisions Improvement Reform and Efficiency (EXPIRE) Act (tax extenders), including the R&D tax credit.
GENENTECH INC via GENENTECH, INC
2014 · first_quarter · 1A
Proposed changes in global patent protections. Compulsory License Issues in India, trade related issues.
Monitor Drug Safety and pedigree legislation. Monitor legislation and oversight on compounding pharmacies., Public Law 111-148, the Patient Protection and Affordable Care Act - Implementation issues related to FDA approval of follow-on biologics and length of data exclusivity period, 340B drug pricing program, structure of the Medicare presciption drug benefit. Public Law 111-152, the Health Care and Education Reconciliation Act of 2010- Implementation issues related to Medicare and Medicaid reimbursement, fees assessd on the pharmaceutical industry, design and structure of the Medicare prescription drug benefit. Public Law 112-144, the Food and Drug Administration Safety and Innovation Act - legislation related to reauthorization of user fees for prescription drug, medical device, and bilogics approval. All aspects. General issues and congressional oversight related to FDA approval and CMS coverage decisions regarding Avastin and Lucentis. S. 959 - Pharmaceutical Quality, Security, and Accountability Act- legislation regardng pharmacy compounding and track and trace proposals. Public Law 113-67, Continuing Appropriations Resolution for 2014 - General public health spending.
GENENTECH INC via GENENTECH, INC
2014 · first_quarter · Q1
Proposed changes in global patent protections. Compulsory License Issues in India, trade related issues.
FY13 Labor, HHS and Education Appropriation related to preparedness for pandemic influenca, HIV/AIDS programs, hepatitis screening, care and treatment, and access t breast cancer treatment; Following issues related to the budget and appropriations process FY 13 appropriations for FDA as well as the potential outcomes for negotiations on altering sequestration targets via legislation, Issues related to FDA & HHS program funding, FY15 Labor Health and Human Services, and Education, and Related Agencies, and FY 15 Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Bills.
GENENTECH INC via GENENTECH, INC
2013 · fourth_quarter · Q4
Cyber security, Transpacific partnership
Proposed changes in global patent protections, compulsory license issues in India
tax reform, general corporate and international taxation; Genteral tax issues and tax extenders (R&D tax credit) and tax treatment of foreign-owned U.S. corporations; Research and Development Tax credit; Issues related to comprehensive tax reform, tax treatment of and tax extenders, including R&D tax credit. Corporate tax reform issues. International trade issues and patent protection abroad.
GENENTECH INC via GENENTECH, INC
2013 · third_quarter · Q3
Monitoring of the FY 14 appropriations bills and issues related to comprehensive tax reform.; Research and Development Tax credit,; general tax issues and tax extenders (R&D tax credit) and tax treatment of foreign-owned US corporations
Trade with India.; Proposed changes in global patent protections. Compulsory License Issues in India
FY13 Labor, HHS and Education Appropriation related to preparedness for pandemic influenza, HIV/AIDS programs, hepatitis screening, care and treatment, and access t breast cancer treatment; Following issues related to the budget and appropriations process FY 13 appropriations for FDA as well as the potential outcomes for negotiations on altering sequestration targets via legislation
GENENTECH INC via GENENTECH, INC
2013 · second_quarter · Q2
Monitoring of the FY 14 appropriations bills and issues related to comprehensive tax reform; R&D Tax Credit issues; S. 3521, Family and Business Tax Cut Certainty Act of 2012; S. 1577 Greater Research Opportunities with Tax Help Act; H.R. 942, American Research and Competitiveness Act of 2011; H.R. 8; Research and Development Tax credit, general tax issues and tax extenders (R&D tax credit) and tax treatment of foreign-owned US corporations.
Pandemic preparedness, Tamiflu, Medicare coverage of Cancer Drugs, Appropriations.; S.959, Pharmaceutical Compounding Quality and Accountability Act; H.R. 1416, Cancer Patient Protection Act of 2013; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; compounding issues; FY 13 Labor HHS Appropriations legislation; issues related to FDA user fee reauthorization; H.R. 942 S. 1577; S. 3187; Pedigree and biologics issues; H.R. 905: ASP issues; H.R. 5651; issues concerning drug compounding. Implementation of Patient Protection and Affordable Care Act; Legislation on public health preparedness and response related to pandemic influenza. Influenza Pandemic Preparedness federal, state and local levels. Legislation on screening, care and treatment for hepatitis; implementation of section 340B of the Public Health Service Act (42 U.S.C. 256b); Implementation of H.R. 1: Medicare Prescription Drug and Modernization Act of 2003; Issues relating to PDUFA stimulus. Avastin-use in breast cancer treatment: general patient reform isse: implementation of the Affordable Care Act of 2010; Issues relating to the treatment of biologics in international health programs.
GENENTECH INC via GENENTECH, INC
2013 · first_quarter · Q1
Tax reform;Issues related to FDA & HHS program funding, FY13 Labor Health and Human Services, and Education, and Related Agencies Appropriations bill.;Following issues related to the budget and appropriations process FY 13 appropriations for FDA as well as the potential outcomes for negotiations on altering sequestration targets via legislation; FY13 Labor, HHS and Education Appropriation related to preparedness for pandemic influenza, HIV/AIDS programs, hepatitis screening, care and treatment, and access to breast cancer treatment; FY13 appropriations bills, including issues related to FDA funding and drug approval/review oversight process. FY13 sequestration process; Issues related to comprehensive tax reform, tax treatment of foreign-owned U.S. corporations, and tax extenders, including R&D tax credit. International trade issues and patent protection abroad; FY 14 appropriations process.
Tax reform; general tax issues and tax extenders (R&D tax credit) and tax; Research and Development Tax credit; Specific issues lobbied (bill numbers): R&D Tax Credit issues; S. 3521, Family and Business Tax Cut Certainty Act of 2012; S. 1577 Greater Research Opportunities with Tax Help Act; H.R. 942, American Research and Competitiveness Act of 2011; H.R. 8
GENENTECH INC via GENENTECH, INC
2012 · fourth_quarter · Q4
FY14 appropriations bills, including issues related to FDA funding and drug approval/review oversight process; issues related to comprehensive tax U.S. corporations, and tax extenders, including R&D tax credit. S.3521, Family and Business Tax Cut Certanity Act of 2012 (tax "extenders"). Corporate tax reform issues. Fiscal cliff legislation. American Taxpayer relief act (HR 8); R&D Tax Credit issues; S. 3521, S.1577, Greater Research Opportunities with Tax Help Act: H.R. 942, American Research and Competitiveness Act of 2011; HR. 8; Research and Development Tax credit, year-end tax issues: Monitoring proposals on US tax treatment of foreign-owned US corporations;
FY13 Labor, HHS and Education Appropriation related to preparedness for pandemic influenza, HI/AID programs, hepatitis screening, care and treatment and access to breast cancer treatment; issues related to FDA &HHA program funding, FY13 Labor Health and Human Services and Education and related agencies appropriations bill.
GENENTECH INC via GENENTECH, INC
2012 · third_quarter · Q3
FY13 Labor, HHS and Education Appropriation related to preparedness for pandemic influenza, HIV/AIDS programs, hepatitis screeinng, care and treatmen, and access to breast cancer treatment.;Following issues related to the budget and appropriations process FY 13 appropriations for FDA as awell as the potential outcomes for negotiations on altering sequestration targets via legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH INC via GENENTECH, INC
2012 · second_quarter · Q2
Implementation of H.R. 1: Medicare Prescription Drug and Modernization Act of 2003; Issues relating to PDUFA, stimulus, issues relating comparative effectiveness and CMS coverage of FDA approved therapies. Legislation on public health preparedness and response related to pandemic influenza. Avastin-use in breast cancer treatment; general patent reform issues; implementation of the Affordable Care Act of 2010; Implementation of healthcare reform law. FDA Drug Approval and appeal oversight process. Issues related to patient and physician choice in medical treatments. Monitor PDUFA reauthorization.; Monitor implementation of Medicare pharmaceutical coverage and reimbursement and 340B provisions if the Affordable Care Act; Advocacy related ensuring access to necessary medicines
R&D Tax Credit (H.R. 942), FDA Appropriations, PDUFA Reauthorization; general tax issues and tax extenders (R&D tax credit) and tax treatment of foreign-owned U.S. corporations; Worked to garner support for H.R. 942, the AmericanResearch and Competitiveness Act of 2011; Monitoring proposals on US tax treatment of foreign-owned U.S. corporations;
GENENTECH INC via GENENTECH, INC
2012 · first_quarter · Q1
General Tax issues and tax extenders
Medicare Prescription Drug and Modernization Act of 2003; Issues relating comparative effectiveness and CMS coverage of FDA approved therapies. Issues related to the PPS rule involving stroke guidelines. Proposals to reduce Medicare payment for Part B biologics; payment policies for prescription drugs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH INC via GENENTECH, INC
2011 · first_quarter · 1A
Avastin, Lucentis, FDA, Appropriations; Issues concerning clinical trias. General health care reform (Patient Protection and Affordable Care Act). Congressional oversight issues; Legislation on public health preparedness and response to pandemic influenza. Influenza Pandemic Preparedness federal, state and local levels; FDA approval and enforcement issues; Prescription Drug User Fee Act (PDUFA), Avastin - use in breast cancer treatment, macular degeneration, S.726/HR 1427 - Promoting Innovation and Access to Life-Saving Medicine Act; HR 1548 - Pathway for Biosimilars Act, General support for Genentech products; HR1/1473 health care funding : FY 12 Labor HHS Appropriations legislation.
General tax issues and tax extenders; Monitoring proposals on U.S. tax treatment of foreign corporations;
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH INC via GENENTECH, INC
2011 · fourth_quarter · Q4
Advocacy related ensuring access to necessary medicines; implementation of H.R. and Modernization Act of 2003; Issues relating to PDUFA, stimulus, issues relating comparative effectiveness and CMS coverage of FDA approved therapies; Medicare coverage and payment of Part B drugs and biologics; Support for H.R. 452 Medicare Decision Accountability Act of 2011 and S.668: "Health Care Bureaucrats Elimination Act"; FDA approval and enforcement issues,340B payment and implementation issues; Medicare issues; Monitor implementation of Medicare Pharmaceutical coverage and reimbursement 340B provisions of the Affordable Care Act
Patent Reform Act; general Patent reform issues; H.R.243 Patent Lawsuit Reform Act of 2011; H.R. 1249 Leahy-Smith America Invents Act S.23 - America Invents Act;
GENENTECH INC via GENENTECH, INC
2011 · third_quarter · Q3
Implement of H.R.: Miedicare Prescription Drug and Modernization Act of 2003: Issures relating to PDUFA stimulus, issues relation to comparative effectivness and CMS coverage of FDA approved therapies, issues related to the PPS rule involving stroke guidelines. Implementation of the follow-on bilogice provisions in P.L. 111-148 - "Patient Protection and Affordable Care Act"HR 1/1473 helath care funding; FY12 Labor HHS Appropriations legislation, advocate for approval of Avasitn for late stage breast cancer treatment, Implementation of the Affordable Care of Act of 2010, Advocacy related to ensuring access to necessary medicines, Avastin PDUFA Reauthorization, issues related to pandemic preparedness and mascular degeneration, FDA approval and enforcement issues, 340B payment and implementation issues.
Monitor and report on Food safety and supply chain issues
GENENTECH INC via GENENTECH, INC
2011 · second_quarter · Q2
HCR: Public Law 111-148, the Patient Protection and Affordable Care Act - Implementation issues related to Medicare and Medicaid reimbursement for biotherapeutics, comparative effectiveness research, and FDA approval of follow on biologics. Public law111-152, the Health Care and Education Reconciliation Act of 2010 - Implementation issues related to Medicare and Medicaid payment for biotherapeutics, the 340B program, and Medicared drug benefit.; Prescription Drug User Fee Act (PDUFA); Avastin - use in breast cancer treatment; Legislation on public health preparedness and response related to pandemic influenza. Influenza Pandemic preparedness federal, state and local levels. Legislation on screening, care and treatment for hepatitis. Implementation of the Affordable Care Act of 2010; Advocate for approval of Avastin for late stage breast cancer treatment; HR 1/1473 - health care funding: FY12 Labor HHS Appropriations legislation Congress and Federal Agencies: U.S. House of Representatives; US Sentate; Implementation of HR 1; Medicare Prescription Drug and Modernization Act of 2003; Issues relating to PDFUA, stimulus. Issues relatiing to comparative effectiveness and CMS coverage of FDA approved therapies. Issues related to the PPS rule involving stroke guidelines. Implementation of the follow-on biolotics provisions in P.L. 111-148 - "Patient Protection and Affordable Care Act"; FDA approval and enforcement issues.
GENENTECH INC via GENENTECH, INC
2011 · first_quarter · Q1
Avastin, Lucentis,FDA Appropriations; Issues concerning clincial trials. General health care reform (Patient Protection and Affordable Care Act). Congressional oversight issues; Legislation on public health preparedness and response to pandemic influenza. Influenza Pandemic Preparedness federal, state and local levels; FDA approval and enforcement issues; Presciption Drug User Fee Act (PDUFA), Avastin -use in breast cancer treatment, dry macular degeneration; S.726/HR 1427 - Promoting Innovation and Access to Life-Saving Medicine Act; HR 1548 - Pathway for Biosimilars Act, General support for Genentech products; HR1/1473 health care funding: FY 12 Labor HHS Appropriations legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH INC via GENENTECH, INC
2010 · fourth_quarter · 4A
S.515 & H.R. 1260 - Patent Reform Act of 2009
Labor HHS Appropriations - S.3230 & H.R. 3042, Homeland Security Appropriations S.3181 and HR 6947; Congress and Federal agencies: US House of Representatives: US Senate: HHS; Dept. of Homeland Security; Executive Office of the President; Office of Personnel Manangement; Dept., of Veteran Affairs
Monitor issues related to export rules and regulations, international patent issues, WTO matters and other international issues impacting biotech and pharmaceuticals.
Intellectual Property and Process Patent Issues - (all provisions), Cyber security, Transpacific partnership
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Research and Development Tax credit,general tax issues and tax extenders (R&D tax credit) and tax treatment of foreign-owned US corporations; tax reform, Issues related to comprehensive tax reformand the tax treatment of foreign-owned U.S. corporations. S__, Expiring Provisions Improvement Reform and Efficiency (EXPIRE) Act (tax extenders), including the R&D tax credit.
FY13 Labor, HHS and Education Appropriation related to preparedness for pandemic influenca, HIV/AIDS programs, hepatitis screening, care and treatment, and access t breast cancer treatment; Following issues related to the budget and appropriations process FY 13 appropriations for FDA as well as the potential outcomes for negotiations on altering sequestration targets via legislation, Issues related to FDA & HHS program funding, FY15 Labor Health and Human Services, and Education, and Related Agencies, and FY 15 Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Bills.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Monitor Drug Safety and pedigree legislation. Monitor legislation and oversight on compounding pharmacies., Public Law 111-148, the Patient Protection and Affordable Care Act - Implementation issues related to FDA approval of follow-on biologics and length of data exclusivity period, 340B drug pricing program, structure of the Medicare presciption drug benefit. Public Law 111-152, the Health Care and Education Reconciliation Act of 2010- Implementation issues related to Medicare and Medicaid reimbursement, fees assessd on the pharmaceutical industry, design and structure of the Medicare prescription drug benefit. Public Law 112-144, the Food and Drug Administration Safety and Innovation Act - legislation related to reauthorization of user fees for prescription drug, medical device, and bilogics approval. All aspects. General issues and congressional oversight related to FDA approval and CMS coverage decisions regarding Avastin and Lucentis. S. 959 - Pharmaceutical Quality, Security, and Accountability Act- legislation regardng pharmacy compounding and track and trace proposals. Public Law 113-67, Continuing Appropriations Resolution for 2014 - General public health spending.
Research and Development Tax credit,general tax issues and tax extenders (R&D tax credit) and tax treatment of foreign-owned US corporations; tax reform, Issues related to comprehensive tax reformand the tax treatment of foreign-owned U.S. corporations. S__, Expiring Provisions Improvement Reform and Efficiency (EXPIRE) Act (tax extenders), including the R&D tax credit.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Implementation of H.R. 1: Medicare Prescription Drug and Modernization Act of 2003; Issues relating to PDUFA,stimulus. Issues relating to comparative effectiveness and CMS coverage of FDA approved therapties. Issues related to the PPS ruel involving stroke guidelines. Implementation of the follow-on biologice provisions in P.L. 111-148- "Patient Protection and Affordable Care Act"; legislation on public health preparedness and response related to pandemic influenza. Influenz Pandemic Preparedness federal, state and local levels. Legislation on screening, care and treatment for hepatitis; FDA Approval and enforcement issues. Issues relating to S.3187, FDA Safety and Innovation Act. Issues relating to antibiotic development incentives in HR 2182 and S 1734, "Generating Antibiotic Incentives Now Act of 2011"; Prescription Drug User Fee Act (PDUFA) Reauthorization;Issues related to the implementationof the Affordable Care Act of 2010;
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Monitoring proposals on US tax treatment of foreign-owned U.S. corporations;
Monitor issues related to export rules and regulations, international patent issues, WTO matters, the Trans-Pacific Partnership and other international issues impacting biotech and pharmaceuticals;
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Budget/Appropriations: FY12 appropriations process, including H.R. 2112 and various continuing resolutions: FDA funding issues and drug approval/review oversight process.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Intellectual Property and Process Patent Issues; HR 1908, Patent Reform Act (all provisions); S.23 - Patent Reform Act; General Patent Reform Issues; Specfic issues lobbied (bill numbers): Patent reform legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Labor HHS appropriations stock piling anti-virals for pandemic influenza; Cancer Research Issues - S.3686/HR_, Labor, HHS Appropriations Bill for FY2011; Monitoring the implementation for the Patient Protection and Affordable Care Act, including provisions related to comparative effectiveness research and a regulatory pathway for biosimilars; H.R.1 - Pandemic influenza funding: H.R.1105 Omnibus Appropriations Act of 2010, Food Safety Bill, H.R. 4872 Health Care& Education Reconciliation Act of 2011; issues concerning clincial trials; general health care reform (Patient Protection and Affordable Care Act); Congressional oversight issues; FDA approval and enforcement issues; Pandemic preparedness; Tamiflu; Avastin-breast cancer; following all issues related to health care reform; S.726/HR 1427 - promotiong innovation and access to life-saving Medicine Act; HR 1548 - Pathway for Biosimilars Act; General support for Genentech products; monitor and report on issues relate to implementation to health care reform; H.R. 1548 - Pathway for Biosimilars Act
Various issues related to the budget and appropriations process
Monitor and report on corporate tax issues; general tax issues and tax extenders
Monitor and report on food safety and supply chain issues
Medicare issues; payment policies for prescription drugs; implementation of H.R.1; Medicare Prescription Drug and Modernization Act of 2003; Issues relating to PDUFA, stimulus; physician payment disclosure including S.301; Physician Payments Sunshine Act of 2009; HR 3962, Affordable Health Care for Americans Act; HR 3590, Patient Protection and Affordable Care Act; H.R.4872, the Reconciliation Act of 2010; Follow-on biologics including H.R. 154, the Pathway to Biosimilars Act; S726/H.R. 1427 Promoting innovation and access to Life Savings Medicines Act; HR 3962, Affordable Health Care for America Act; Compartiveffectiveness legislation S. 1213; Patient-Centered Outcomes Research Act of 2009; HR 3200, America's Health Future Act; H.R. 1548-Pathway for Dissimilar Act; Legislative changes in health care reform bill regarding dissimilar; Follow-on biolotics provisions in P.L. 111-148 "Patient protection and Affordable Care Act", Affordable Health Choice Act; American Health Future Act of 2009; Pharmaceutical Import Safety legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE